Delivery Order SGE50008D0004-SGE50009F0102

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a Firm Fixed Price Delivery Order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $130,151.30, is to provide the Roche Cobas R 4800 and Cobas R 6800 systems and associated reagents, which are validated, PEPFAR approved, WHO prequalified, and FDA approved for HIV viral load and early infant diagnosis...

This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide LAB SUPPLIES LINEAR ARRAY KITS. The contract, valued at $148,800.00, is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type. The place of performance is Atlanta, Georgia. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in...

The Centers for Disease Control and Prevention (CDC) awarded a $93,496 purchase order to Roche Diagnostics Corporation for the delivery of Roche COBAS C6800/AMPLIPREP/CAPTAQ systems. This firm fixed price contract will provide the CDC's Pittsburgh location with laboratory equipment and supplies to support its disease testing and prevention efforts. Roche will deliver the requested products to the CDC site in Castleton, Indiana by October 25, 2023. No subcontractors or set aside designations were...

Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $572,044.24 by the Centers for Disease Control and Prevention (CDC) Pittsburgh for maintenance services on COBAS HIV equipment with operations support. The contract, awarded on July 17, 2024, carries an ultimate completion date of September 4, 2028, and will be performed in Castleton, Indiana. This award represents a non-competitive procurement with no set-aside designation, reflecting Roche's established...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $143,672.81 contract is for ROCHE REAGENTS AND SUPPLIES with a completion date of December 31, 2018. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...

This federal contract award with ID HHSD2002017M92821P was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $99,695.80 firm fixed price purchase order is for Roche lab equipment and supplies, with a completion date of January 27, 2017. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and other...

The Centers for Disease Control and Prevention (CDC) awarded a sole-source, firm-fixed-price purchase order to Roche Diagnostics Corporation to provide biomedical reagents, testing supplies, and commodities required to conduct HIV molecular laboratory testing. The $25,725.24 contract has an ultimate completion date of October 17, 2029. The requirement is not set aside, as Roche Diagnostics is identified as the only vendor capable of providing the proprietary reagents and supplies compatible with...

This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...

This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the purchase of COBAS PURE C303/E402 clinical chemistry analyzers and associated reagents and supplies. The $460,000.00 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh on April 24, 2023, with an ultimate completion date of December 31, 2023. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned,...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, for the supply of lab supplies. The potential value of the contract is $119,383.20, and the period of performance runs through April 1, 2019. The contract does not have a set-aside designation. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and...